Not applicableUnknownNCT04908059What this trial is testingLeukemic Phase of ALCLWho this might be right forAnaplastic Lymphoma University Hospital, Strasbourg, France 2
Early research (Phase 1)Active Not RecruitingNCT06325748What this trial is testingSENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDSWho this might be right forAML/MDSCD33 Expressing Hematological MalignanciesFLT3 Expressing Hematological Malignancies Senti Biosciences 21
Early research (Phase 1)Study completedNCT00320827What this trial is testingStudy of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component)Who this might be right forMalignanciesLymphoma Daiichi Sankyo 40
Testing effectiveness (Phase 2)Study completedNCT00171249What this trial is testingAn Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ LeukemiaWho this might be right forPhiladelphia Positive Chronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia Novartis Pharmaceuticals 293
Early research (Phase 1)Study completedNCT05326516What this trial is testingRevumenib in Combination With Chemotherapy in Participants With R/R Acute LeukemiaWho this might be right forRelapsed/Refractory LeukemiasAcute Lymphoblastic LeukemiaAcute Lymphocytic Leukemia+3 more Syndax Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT01658241What this trial is testingPanobinostat Biological Correlates StudyWho this might be right forNodal LymphomaLymphoma With Cutaneous InvolvementLymphoma in Leukemic Phase+2 more Peter MacCallum Cancer Centre, Australia 30